Nasodine Patent Allowed in Canada


Highlights Firebrick Pharma Limited (ASX:FRE) is pleased to announce that its core patent covering NasodineĀ® Nasal Spray as a treatment and preventative for the common cold has now been allowed in Canada. Once this proceeds to grant, it will bring the number of countries where this patent has been granted to 28, now covering North…